BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 36606668)

  • 21. MicroRNA-196a promotes cervical cancer proliferation through the regulation of FOXO1 and p27Kip1.
    Hou T; Ou J; Zhao X; Huang X; Huang Y; Zhang Y
    Br J Cancer; 2014 Mar; 110(5):1260-8. PubMed ID: 24423924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-141-3p is upregulated in esophageal squamous cell carcinoma and targets pleckstrin homology domain leucine-rich repeat protein phosphatase-2, a negative regulator of the PI3K/AKT pathway.
    Ishibashi O; Akagi I; Ogawa Y; Inui T
    Biochem Biophys Res Commun; 2018 Jun; 501(2):507-513. PubMed ID: 29738771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-125 inhibited cervical cancer progression by regulating VEGF and PI3K/AKT signaling pathway.
    Fu K; Zhang L; Liu R; Shi Q; Li X; Wang M
    World J Surg Oncol; 2020 May; 18(1):115. PubMed ID: 32473637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DEPTOR promotes survival of cervical squamous cell carcinoma cells and its silencing induces apoptosis through downregulating PI3K/AKT and by up-regulating p38 MAP kinase.
    Srinivas KP; Viji R; Dan VM; Sajitha IS; Prakash R; Rahul PV; Santhoshkumar TR; Lakshmi S; Pillai MR
    Oncotarget; 2016 Apr; 7(17):24154-71. PubMed ID: 26992219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-125b inhibits cell biological progression of Ewing's sarcoma by suppressing the PI3K/Akt signalling pathway.
    Li J; You T; Jing J
    Cell Prolif; 2014 Apr; 47(2):152-60. PubMed ID: 24517182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
    Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
    Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-520a-3p inhibits cell growth and metastasis of non-small cell lung cancer through PI3K/AKT/mTOR signaling pathway.
    Lv X; Li CY; Han P; Xu XY
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2321-2327. PubMed ID: 29762835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-494 promotes cervical cancer proliferation through the regulation of PTEN.
    Yang YK; Xi WY; Xi RX; Li JY; Li Q; Gao YE
    Oncol Rep; 2015 May; 33(5):2393-401. PubMed ID: 25738254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of miR-214 on cervical cancer cell proliferation, apoptosis and invasion via modulating PI3K/AKT/mTOR signal pathway.
    Wang F; Tan WH; Liu W; Jin YX; Dong DD; Zhao XJ; Liu Q
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1891-1898. PubMed ID: 29687840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circular RNA circ_0006089 promotes the progression of gastric cancer by regulating the miR-143-3p/PTBP3 axis and PI3K/AKT signaling pathway.
    Lin GR; Chen WR; Zheng PH; Chen WS; Cai GY
    J Dig Dis; 2022 Jul; 23(7):376-387. PubMed ID: 35844201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA miR-23b-3p promotes osteosarcoma by targeting ventricular zone expressed PH domain-containing 1 (VEPH1)/phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) pathway.
    Fan L; Cao X; Lei Y
    Bioengineered; 2021 Dec; 12(2):12568-12582. PubMed ID: 34903122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cleavage stimulation factor 2 promotes malignant progression of liver hepatocellular carcinoma by activating phosphatidylinositol 3'-kinase/protein kinase B/mammalian target of rapamycin pathway.
    Zhang MH; Liu J
    Bioengineered; 2022 Apr; 13(4):10047-10060. PubMed ID: 35412944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
    Li KW; Wang SH; Wei X; Hou YZ; Li ZH
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
    Gu Y; Fei Z; Zhu R
    Anticancer Drugs; 2020 Apr; 31(4):385-393. PubMed ID: 31913198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OSCC Exosomes Regulate miR-210-3p Targeting EFNA3 to Promote Oral Cancer Angiogenesis through the PI3K/AKT Pathway.
    Wang H; Wang L; Zhou X; Luo X; Liu K; Jiang E; Chen Y; Shao Z; Shang Z
    Biomed Res Int; 2020; 2020():2125656. PubMed ID: 32695810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
    BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-199a-3p inhibits angiogenesis by targeting the VEGF/PI3K/AKT signalling pathway in an in vitro model of diabetic retinopathy.
    Wang L; Liu WX; Huang XG
    Exp Mol Pathol; 2020 Oct; 116():104488. PubMed ID: 32622012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway.
    Li B; Guo X; Li N; Chen Q; Shen J; Huang X; Huang G; Wang F
    Cell Oncol (Dordr); 2020 Jun; 43(3):489-503. PubMed ID: 32301035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Up-regulation of miR-20a by HPV16 E6 exerts growth-promoting effects by targeting PDCD6 in cervical carcinoma cells.
    Liu X
    Biomed Pharmacother; 2018 Jun; 102():996-1002. PubMed ID: 29710555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hsa_circ_CSPP1/MiR-361-5p/ITGB1 Regulates Proliferation and Migration of Cervical Cancer (CC) by Modulating the PI3K-Akt Signaling Pathway.
    Yang W; Xie T
    Reprod Sci; 2020 Jan; 27(1):132-144. PubMed ID: 32046405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.